Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cells.

Kang HG, Jenabi JM, Liu XF, Reynolds CP, Triche TJ, Sorensen PH.

Mol Cancer Ther. 2010 May;9(5):1396-407. doi: 10.1158/1535-7163.MCT-09-0604.

2.

Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor.

Martins AS, Mackintosh C, Martín DH, Campos M, Hernández T, Ordóñez JL, de Alava E.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3532-40.

3.

Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.

Tang Y, Zhao DY, Elliott S, Zhao W, Curiel TJ, Beckman BS, Burow ME.

Int J Oncol. 2007 Oct;31(4):705-11.

PMID:
17786300
4.

Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.

Spinella F, Rosanò L, Di Castro V, Decandia S, Albini A, Nicotra MR, Natali PG, Bagnato A.

Mol Cancer Ther. 2006 Jun;5(6):1483-92.

5.

(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.

Shirakami Y, Shimizu M, Adachi S, Sakai H, Nakagawa T, Yasuda Y, Tsurumi H, Hara Y, Moriwaki H.

Cancer Sci. 2009 Oct;100(10):1957-62. doi: 10.1111/j.1349-7006.2009.01241.x.

8.

Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer.

Shankar S, Suthakar G, Srivastava RK.

Front Biosci. 2007 Sep 1;12:5039-51.

PMID:
17569628
9.

Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.

Harper CE, Patel BB, Wang J, Eltoum IA, Lamartiniere CA.

Prostate. 2007 Oct 1;67(14):1576-89.

PMID:
17705241
10.

(-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.

Shimizu M, Shirakami Y, Sakai H, Yasuda Y, Kubota M, Adachi S, Tsurumi H, Hara Y, Moriwaki H.

Chem Biol Interact. 2010 May 14;185(3):247-52. doi: 10.1016/j.cbi.2010.03.036.

PMID:
20346928
11.

Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.

Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H.

Cancer Res. 2006 Mar 1;66(5):2500-5. Review.

12.

Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation.

Li M, He Z, Ermakova S, Zheng D, Tang F, Cho YY, Zhu F, Ma WY, Sham Y, Rogozin EA, Bode AM, Cao Y, Dong Z.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):598-605.

16.

EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.

Shimizu M, Shirakami Y, Sakai H, Tatebe H, Nakagawa T, Hara Y, Weinstein IB, Moriwaki H.

Cancer Lett. 2008 Apr 8;262(1):10-8. doi: 10.1016/j.canlet.2007.11.026.

PMID:
18164805
17.
18.

A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins.

Qin J, Xie LP, Zheng XY, Wang YB, Bai Y, Shen HF, Li LC, Dahiya R.

Biochem Biophys Res Commun. 2007 Mar 23;354(4):852-7.

PMID:
17266926
19.

Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.

Shammas MA, Neri P, Koley H, Batchu RB, Bertheau RC, Munshi V, Prabhala R, Fulciniti M, Tai YT, Treon SP, Goyal RK, Anderson KC, Munshi NC.

Blood. 2006 Oct 15;108(8):2804-10.

20.

Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.

Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.

Cancer Lett. 2007 Jan 8;245(1-2):232-41.

PMID:
16519995
Items per page

Supplemental Content

Support Center